RecruitingNCT01694940
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
Sponsor
Columbia University
Enrollment
1,000 participants
Start Date
Jan 31, 2011
Study Type
OBSERVATIONAL
Conditions
Summary
The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients with mitochondrial disorders.
Eligibility
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with deletion and duplication of mitochondrial dna, disorder of mitochondrial respiratory chain complexes, and other related conditions. The study is currently recruiting participants at 17 locations.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(17)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01694940
Related Trials
Global Registry and Natural History Study for Mitochondrial Disorders
NCT0555483533 locations
The NIH MINI Study: Metabolism, Infection, and Immunity in Inborn Errors of Metabolism
NCT017801681 location
KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
NCT0645175710 locations
Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
NCT043227342 locations
The Natural History of Mitochondrial Diseases
NCT065044331 location